基于SFMA理论指导针刺肌筋膜触发点治疗慢性腰背痛的临床研究

注册号:

Registration number:

ITMCTR2025000836

最近更新日期:

Date of Last Refreshed on:

2025-04-24

注册时间:

Date of Registration:

2025-04-24

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

基于SFMA理论指导针刺肌筋膜触发点治疗慢性腰背痛的临床研究

Public title:

Clinical Study on Acupuncture at Myofascial Trigger Points for Chronic Low Back Pain Guided by SFMA Theory

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于SFMA理论指导针刺肌筋膜触发点治疗慢性腰背痛的临床研究

Scientific title:

Clinical Study on Acupuncture at Myofascial Trigger Points for Chronic Low Back Pain Guided by SFMA Theory

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

刘传淮

研究负责人:

刘传淮

Applicant:

Chuanhuai Liu

Study leader:

Chuanhuai Liu

申请注册联系人电话:

Applicant telephone:

15880430326

研究负责人电话:

Study leader's telephone:

15880430326

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

liuch313@163.com

研究负责人电子邮件:

Study leader's E-mail:

liuch313@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

泉州市鲤城区金龙街道高山社区笋江路388号

研究负责人通讯地址:

泉州市鲤城区金龙街道高山社区笋江路388号

Applicant address:

No. 388 Sunjiang Road Gaoshan Community Jinlong Street Licheng District Quanzhou City

Study leader's address:

No. 388 Sunjiang Road Gaoshan Community Jinlong Street Licheng District Quanzhou City

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

泉州市中医院

Applicant's institution:

Quanzhou Hospital of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

(2025)泉中医伦理审字第(007)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件

批准本研究的伦理委员会名称:

泉州市中医院医学伦理委员会

Name of the ethic committee:

Quanzhou Traditional Chinese Medicine Hospital Medical Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2025/3/8 0:00:00

伦理委员会联系人:

凌珍美

Contact Name of the ethic committee:

zhenmei ling

伦理委员会联系地址:

泉州市鲤城区金龙街道高山社区笋江路388号

Contact Address of the ethic committee:

No. 388 Sunjiang Road Gaoshan Community Jinlong Street Licheng District Quanzhou City

伦理委员会联系人电话:

Contact phone of the ethic committee:

13805925088

伦理委员会联系人邮箱:

Contact email of the ethic committee:

184969803@qq.com

研究实施负责(组长)单位:

泉州市中医院

Primary sponsor:

Quanzhou Hospital of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

泉州市鲤城区金龙街道高山社区笋江路388号

Primary sponsor's address:

No. 388 Sunjiang Road Gaoshan Community Jinlong Street Licheng District Quanzhou City

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

福建

市(区县):

泉州

Country:

China

Province:

Fujian

City:

Quanzhou

单位(医院):

泉州市中医院

具体地址:

泉州市鲤城区金龙街道高山社区笋江路388号

Institution
hospital:

Quanzhou Hospital of Traditional Chinese Medicine

Address:

No. 388 Sunjiang Road Gaoshan Community Jinlong Street Licheng District Quanzhou City

经费或物资来源:

泉州市科技局

Source(s) of funding:

Quanzhou Science and Technology Bureau

研究疾病:

慢性腰背部

研究疾病代码:

Target disease:

Chronic Low Back Pain

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

治疗新技术临床试验

New Treatment Measure Clinical Study

研究目的:

本研究旨在通过随机对照试验,验证基于SFMA理论指导针刺肌筋膜触发点治疗慢性腰背痛的临床疗效。通过对比SFMA评估引导的远端功能干预与常规局部针刺,结合肌骨超声量化核心肌群功能、ODI指数及SFMA评分,探索“疼痛-运动模式-结构”多维度干预机制,为中西医结合治疗提供新思路,改善患者功能预后,降低复发率,减轻医疗负担。

Objectives of Study:

This study aims to validate the clinical efficacy of SFMA (Selective Functional Movement Assessment)-guided acupuncture at myofascial trigger points for chronic low back pain (CLBP) through a randomized controlled trial. By comparing SFMA-guided distal functional intervention with conventional local acupuncture, integrating musculoskeletal ultrasound quantification of core muscle function (transverse abdominis and multifidus contraction rates), Oswestry Disability Index (ODI) scores, and SFMA assessments, the research explores the "pain-movement pattern-structure" multidimensional intervention mechanism. The goal is to provide a novel integrative Chinese-Western medicine approach for improving functional outcomes, reducing recurrence, and alleviating healthcare burdens in CLBP patients.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

1. 符合慢性腰痛的定义,以腰痛为主诉就诊; 2. 年龄介于18至75岁之间; 3. 言语交流无障碍,能够配合完成相关检查及量表评估; 4. 自愿参加研究,并签署知情同意书

Inclusion criteria

1.Meet the definition of chronic low back pain and seek medical treatment with low back pain as the main complaint; 2. Age between 18 and 75 years old; 3. Speech communication is barrier-free and able to cooperate with relevant examinations and scale assessments; 4. Volunteer to participate in the study and sign an informed consent form

排除标准:

1.合并多种治疗方法,针刺在腰痛的治疗中仅作为辅助治疗; 2.有心血管、消化、泌尿和造血系统等原发性疾病; 3.腰部肿瘤、感染、外伤等原因引起的腰痛患者; 4.严重的精神病患者; 5.腰椎术后患者; 6.妊娠状态; 7.出现马尾综合征的症状,如大小便障碍、鞍区感觉减退等;

Exclusion criteria:

1. Combined with a variety of treatment methods acupuncture is only used as an adjuvant treatment in the treatment of low back pain; 2. Primary diseases such as cardiovascular digestive urinary and hematopoietic systems; 3. Patients with low back pain caused by lumbar tumors infections trauma etc.; 4. Severe mental illness; 5. Patients with lumbar spine surgery; 6. Pregnancy status; 7. Symptoms of cauda equina syndrome such as defecation disorders hyposenia in the saddle area etc.;

研究实施时间:

Study execute time:

From 2025-12-01

To      2028-11-30

征募观察对象时间:

Recruiting time:

From 2025-12-01

To      2027-11-30

干预措施:

Interventions:

组别:

观察组

样本量:

35

Group:

observation group

Sample size:

干预措施:

针刺SMFA评估筛选后的肌筋膜触发点

干预措施代码:

Intervention:

Acupuncture at the myofascial trigger points screened after the SMFA assessment

Intervention code:

组别:

对照组

样本量:

35

Group:

control group

Sample size:

干预措施:

针刺局部肌筋膜触发点

干预措施代码:

Intervention:

Acupuncture at the local myofascial trigger points

Intervention code:

样本总量 Total sample size : 70

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

福建

市(区县):

泉州

Country:

China

Province:

Fujian

City:

Quanzhou

单位(医院):

泉州市中医院

单位级别:

市级

Institution/hospital:

Quanzhou Hospital of Traditional Chinese Medicine

Level of the institution:

No. 388 Sunjiang Road Gaoshan Community Jinlong Street Licheng District Quanzhou City

测量指标:

Outcomes:

指标中文名:

McGill疼痛问卷

指标类型:

次要指标

Outcome:

McGill Pain Questionnaire

Type:

Secondary indicator

测量时间点:

干预前、干预2周后、干预4周后

测量方法:

量表评估

Measure time point of outcome:

Before the intervention 2 weeks after the intervention and 4 weeks after the intervention

Measure method:

Scale Assessment

指标中文名:

Oswestry 功能障碍问卷量表

指标类型:

次要指标

Outcome:

Oswestry Disability Questionnaire (ODQ)

Type:

Secondary indicator

测量时间点:

干预前、干预2周后、干预4周后

测量方法:

量表评估

Measure time point of outcome:

Before the intervention 2 weeks after the intervention and 4 weeks after the intervention

Measure method:

Scale Assessment

指标中文名:

选择性功能动作评估(SFMA)

指标类型:

主要指标

Outcome:

Selective Functional Movement Assessment

Type:

Primary indicator

测量时间点:

干预前、干预2周后、干预4周后

测量方法:

患者依评估师指令,依次完成深蹲、单腿站立等七个基本动作模式评估。观察动作质量,如流畅性、对称性等,留意有无代偿动作,及完成动作时的疼痛表现、部位及程度。

Measure time point of outcome:

Before the intervention 2 weeks after the intervention and 4 weeks after the intervention

Measure method:

Patients complete the assessments of seven basic movement patterns, such as squatting and single-leg standing, in sequence according to the assessor's instructions. Observe the quality of the movements, such as smoothness and symmetry, pay attention to whether there are compensatory movements, as well as the pain manifestations, locations, and degrees when completing the movements.

指标中文名:

腹横肌与多裂肌的收缩功能

指标类型:

主要指标

Outcome:

The contractile function of transverse abdominis and multifidus

Type:

Primary indicator

测量时间点:

干预前、干预2周后、干预4周后

测量方法:

肌骨超声

Measure time point of outcome:

Before the intervention 2 weeks after the intervention and 4 weeks after the intervention

Measure method:

Musculoskeletal ultrasound

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 18
Min age years
最大 75
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

本试验每组需35例患者,按照纳入受试者的时间依次排序,再按照受试者的序号从随机数字表 中进行选取数字,按照随机数字表预先的设定,把患者随机配到对照组和试验组。

Randomization Procedure (please state who generates the random number sequence and by what method):

This trial requires 35 patients in each group sorted in sequence according to the time of inclusion of the subjects and then selected numbers from the random number table according to the serial number of the subjects. According to the pre-setting of the random number table the patients were randomly assigned to the control group and the experimental group.

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

No sharing

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集和管理由两部分组成,一为病例记录表(CRF),二为电子采集和管理系统:ResMan

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The data collection and management consists of two parts the Case Record Form (CRF) and the electronic collection and management system ResMan.

数据管理委员会:

Data Managemen Committee:

No

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

国际传统医学临床试验注册平台 京ICP备07032215号-5 提示:推荐使用IE8.0以上版本 宽屏显示分辨率下使用系统